Back to search

Article

Location of ryanodine receptor type 2 mutation predicts age of onset of sudden death in catecholaminergic polymorphic ventricular tachycardia – A systematic review and meta-analysis of case-based literature

2024-03-16

Abstract excerpt

<h4>Background</h4> Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia caused by mutations in the ryanodine receptor type 2 (RyR2). Diagnosis of CPVT often occurs after a major cardiac event, thus posing a severe threat to the patient’s health. <h4>Methods</h4> Publication databases, including PubMed, Scopus, and Embase, were searched for articles on patients with RyR2-CPVT...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
57e5a9ca-3cc8-5b5f-bc5c-042e9eb0f6ec
DOI
10.1101/2024.03.15.24304349
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Location of ryanodine receptor type 2 mutation predicts age of onset of sudden death in catecholaminergic polymorphic ventricular tachycardia – A systematic review and meta-analysis of case-based literatureDOI 10.1101/2024.03.15.24304349
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.Semantic proximity
The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.Semantic proximity
Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.Semantic proximity
50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon.Semantic proximity
Genetics, manifestations, and management of catecholaminergic polymorphic ventricular tachycardia.Semantic proximity
Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?Semantic proximity
Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.Semantic proximity
Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.Semantic proximity
Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist.Semantic proximity
Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.Semantic proximity
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.Semantic proximity
Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from ChinaSemantic proximity
Select a neighboring publication to make it the new centre.